Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Efficacy and safety of agomelatine with flexible dose ( 25 mg/day with blinded adjustment at 50 mg) given orally for 8 weeks in Indian outpatients with Major Depressive Disorder A randomised double-blind national multicentric study with parallel groups, versus sertraline ( 50 mg/day with blinded potential adjustment at 100 mg).

Next Previous
Search
Trial Profile

Efficacy and safety of agomelatine with flexible dose ( 25 mg/day with blinded adjustment at 50 mg) given orally for 8 weeks in Indian outpatients with Major Depressive Disorder A randomised double-blind national multicentric study with parallel groups, versus sertraline ( 50 mg/day with blinded potential adjustment at 100 mg).

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 30 Aug 2016

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Agomelatine (Primary) ; Sertraline
  • Indications Major depressive disorder
  • Focus Registrational; Therapeutic Use
  • Sponsors Serdia Pharmaceuticals

    • Most Recent Events

    • 22 Feb 2013 Status changed from recruiting to completed as reported by Clinical Trials Registry - India.
    • 29 Jan 2011 Status changed from not yet recruiting to recruiting as reported by Clinical Trials Registry - India
    • 03 Jan 2011 New trial record

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top